High-Bioactivity Goat Colostrum Powder Preparation Method
Summary
The USPTO has published a patent application detailing a method for preparing a high-bioactivity goat colostrum composite freeze-dried powder. The invention focuses on enhancing the stability and survival rate of probiotics within the powder through encapsulation techniques.
What changed
This document is a patent application (US20260083675A1) filed with the USPTO, describing a novel preparation method for a high-bioactivity goat colostrum composite freeze-dried powder. The method involves specific ratios of goat colostrum powder, composite probiotic liposome freeze-dried powder, and mannose oligosaccharides. Key to the invention is the preparation of modified phytosterol and chitosan to encapsulate probiotics, thereby protecting them and improving their survival rate.
This patent application does not impose immediate regulatory obligations on companies. However, it signifies potential innovation in the food and pharmaceutical sectors related to probiotic stability and delivery. Companies involved in developing or manufacturing probiotic supplements or functional foods may find this technology relevant for future product development or licensing opportunities. Compliance officers should note this as a development in the intellectual property landscape for such products.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HIGH-BIOACTIVITY GOAT COLOSTRUM COMPOSITE FREEZE-DRIED POWDER AND PREPARATION METHOD THEREOF
Application US20260083675A1 Kind: A1 Mar 26, 2026
Inventors
Boxing Chen, Lei Zhang
Abstract
A high-bioactivity goat colostrum composite freeze-dried powder relates to the technical field of food, comprising the following components in parts by weight: 60-70 parts of goat colostrum powder, 5-8 parts of composite probiotic liposome freeze-dried powder, and 6-9 parts of mannose oligosaccharides; the composite probiotic liposome freeze-dried powder is prepared from the following components: gallic acid, phytosterol, soybean phosphatidylcholine, modified chitosan, and probiotic powder; the probiotic powder is Bifidobacterium longum powder or Lactobacillus acidophilus powder. The invention proposes to prepare modified phytosterol by esterification reaction of gallic acid and phytosterol, and to prepare probiotic liposomes by encapsulating probiotics with the modified phytosterol and soybean phosphatidylcholine, and at the same time introduce carboxymethyl into chitosan to prepare modified chitosan, and to prepare composite probiotic liposome freeze-dried powder by encapsulating probiotic liposomes with the modified chitosan, thereby protecting probiotics, thereby reducing the inactivation of probiotics, and improving their survival rate.
CPC Classifications
A61K 9/1277 A61K 9/19 A61K 35/20 A61K 35/745 A61K 35/747 A61K 47/26
Filing Date
2024-10-22
Application No.
18923357
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.